Home › Funds › UBS Group AG › MOLN
UBS Group AG position in MOLN
MOLECULAR PARTNERS AG · Health Care
Latest position (Q2 2026)279 sh
Reported value held$1.08K
Portfolio Weight0.00%
First reportedQ4 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 3.41K | $65.00K | New |
| Q1 2022 | 611 | $12.00K | Reduce |
| Q4 2022 | 2.96K | $19.38K | New |
| Q1 2024 | 326 | $1.26K | New |
| Q2 2024 | 3.46K | $25.02K | Add |
| Q3 2024 | 5.25K | $26.69K | Add |
| Q4 2024 | 6.87K | $32.63K | Add |
| Q1 2025 | 6.35K | $24.64K | Reduce |
| Q2 2025 | 10.20K | $38.96K | Add |
| Q3 2025 | 5.34K | $19.81K | Reduce |
| Q4 2025 | 349 | $1.52K | Reduce |
| Q2 2026 | 279 | $1.08K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding MOLN
- Citadel Advisors 17.18K sh · $65.28K · Q2 2026
- Morgan Stanley 367 sh · $1.42K · Q2 2026